DK1606277T3 - Imidazol-4-yl-ethynyl-pyridinderivater - Google Patents

Imidazol-4-yl-ethynyl-pyridinderivater

Info

Publication number
DK1606277T3
DK1606277T3 DK04717578T DK04717578T DK1606277T3 DK 1606277 T3 DK1606277 T3 DK 1606277T3 DK 04717578 T DK04717578 T DK 04717578T DK 04717578 T DK04717578 T DK 04717578T DK 1606277 T3 DK1606277 T3 DK 1606277T3
Authority
DK
Denmark
Prior art keywords
imidazol
ethynyl
pyridine derivatives
pyridine
derivatives
Prior art date
Application number
DK04717578T
Other languages
Danish (da)
English (en)
Inventor
Bernd Buettelmann
Simona Maria Ceccarelli
Georg Jaeschke
Sabine Kolczewski
Richard Hugh Phillip Porter
Eric Vieira
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1606277T3 publication Critical patent/DK1606277T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK04717578T 2003-03-10 2004-03-05 Imidazol-4-yl-ethynyl-pyridinderivater DK1606277T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03004952 2003-03-10
PCT/EP2004/002276 WO2004080998A1 (fr) 2003-03-10 2004-03-05 Derives de l'imidazol-4-yl-ethynyl-pyridine

Publications (1)

Publication Number Publication Date
DK1606277T3 true DK1606277T3 (da) 2008-08-18

Family

ID=32981724

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04717578T DK1606277T3 (da) 2003-03-10 2004-03-05 Imidazol-4-yl-ethynyl-pyridinderivater

Country Status (30)

Country Link
US (1) US7153874B2 (fr)
EP (1) EP1606277B8 (fr)
JP (1) JP4404896B2 (fr)
KR (1) KR100742019B1 (fr)
CN (1) CN100358889C (fr)
AR (1) AR043501A1 (fr)
AT (1) ATE395345T1 (fr)
AU (1) AU2004220382B2 (fr)
BR (1) BRPI0408093A (fr)
CA (1) CA2516682C (fr)
CL (1) CL2004000449A1 (fr)
CO (1) CO5601027A2 (fr)
DE (1) DE602004013746D1 (fr)
DK (1) DK1606277T3 (fr)
ES (1) ES2305739T3 (fr)
HR (1) HRP20050774A2 (fr)
IL (1) IL170129A (fr)
MX (1) MXPA05009524A (fr)
MY (1) MY135491A (fr)
NO (1) NO20054136L (fr)
NZ (1) NZ541643A (fr)
PA (1) PA8597301A1 (fr)
PE (1) PE20041061A1 (fr)
PL (1) PL1606277T3 (fr)
PT (1) PT1606277E (fr)
RU (1) RU2342383C2 (fr)
SI (1) SI1606277T1 (fr)
TW (1) TWI292318B (fr)
WO (1) WO2004080998A1 (fr)
ZA (1) ZA200506834B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA80888C2 (en) * 2003-06-05 2007-11-12 Hoffmann La Roche Imidazole derivatives as glutmate receptor antagonists
US7452909B2 (en) * 2003-09-04 2008-11-18 Hoffman-La Roche Inc. Imidazole derivatives
NZ551253A (en) * 2004-06-01 2010-07-30 Hoffmann La Roche Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as MGLU5 receptor antagonists
EP1756086B1 (fr) * 2004-06-01 2008-06-04 F.Hoffmann-La Roche Ag Pyridin-4-yl-ethynyl-imidazoles et pyrazoles, antagonistes du recepteur mglur5
EP2258358A3 (fr) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenèse avec un inhibiteur de l'acetylcholinestérase
EP2275095A3 (fr) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenese par modulation des recepteurs muscariniques
EP1940389A2 (fr) 2005-10-21 2008-07-09 Braincells, Inc. Modulation de la neurogenese par inhibition de la pde
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
DE102006011574A1 (de) 2006-03-10 2007-10-31 Grünenthal GmbH Substituierte Imidazo[2,1-b]thiazol-Verbindungen und ihre Verwendung zur Herstellung von Arzneimitteln
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
EP2382975A3 (fr) 2006-05-09 2012-02-29 Braincells, Inc. Neurogénèse par modulation d'angiotensine
AU2007292848A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
MY148217A (en) 2006-12-21 2013-03-29 Hoffmann La Roche Polymorphs of a mglur5 receptor antagonist
WO2010099217A1 (fr) 2009-02-25 2010-09-02 Braincells, Inc. Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine
US8334287B2 (en) 2009-07-17 2012-12-18 Hoffmann-La Roche Inc. Imidazoles
US8586581B2 (en) * 2009-12-17 2013-11-19 Hoffmann-La Roche Inc Ethynyl compounds useful for treatment of CNS disorders
HRP20150555T1 (hr) 2011-04-26 2015-07-03 F. Hoffmann - La Roche Ag Derivati etinila kao pozitivni alosterijski modulatori za mglur5
UA116023C2 (uk) 2013-07-08 2018-01-25 Ф. Хоффманн-Ля Рош Аг Етинільні похідні як антагоністи метаботропного глутаматного рецептора
EP3400220B1 (fr) * 2016-01-05 2021-03-24 Hua Medicine (Shanghai) Ltd. Dérivés de pyrazole
UY37556A (es) 2017-01-10 2018-07-31 Bayer Ag Derivados heterocíclicos como pesticidas
AR113206A1 (es) 2017-01-10 2020-02-19 Bayer Cropscience Ag Derivados heterocíclicos como pesticidas
EP4069685A1 (fr) * 2019-12-02 2022-10-12 F. Hoffmann-La Roche AG Inhibiteurs d'alcynyle- (hétéroaryl)-carboxamide hcn1
CN111416154B (zh) * 2020-05-22 2021-08-06 松山湖材料实验室 高电压锂离子电池电解液硅基吡啶添加剂、电解液及其电池
AU2022251771A1 (en) 2021-03-27 2023-09-21 Syngenta Crop Protection Ag Microbiocidal isonicotinic amide derivatives
WO2023089049A2 (fr) 2021-11-19 2023-05-25 Syngenta Crop Protection Ag Dérivés d'amide isonicotinique microbiocide
JP2026502124A (ja) 2022-12-19 2026-01-21 シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト 殺微生物性ピリダジンジヒドロオキサジアジン誘導体

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3303199A (en) * 1963-07-15 1967-02-07 Geigy Chem Corp Certain imidazolone derivatives and process for making same
US3341548A (en) * 1964-04-29 1967-09-12 Hoffmann La Roche Nitroimidazoles and their preparation
DE2035905A1 (de) 1970-07-20 1972-02-03 Chemische Fabrik Stockhausen & Cie.,4150Krefeld Imidazolverbindungen und deren Herstellungsverfahren
CA1174673A (fr) 1981-02-27 1984-09-18 Walter Hunkeler Imidazodiazepines
US4711962A (en) * 1984-10-18 1987-12-08 Stauffer Chemical Company Process for selective preparation of ratios of isomers formed on N-substitution of asymmetric imidazoles
US4868181A (en) * 1986-08-04 1989-09-19 E. I. Du Pont De Nemours And Company 1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
US4882343A (en) * 1987-08-28 1989-11-21 G. D. Searle & Co. Biarylalkylimidazole derivatives as anti-depressants
SG52709A1 (en) 1989-06-30 1998-09-28 Du Pont Substituted imidazoles
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
CA2297732C (fr) 1997-08-14 2008-04-29 F. Hoffmann-La Roche Ag Ethers heterocycliques de vinyle utiles contre des troubles neurologiques
JP4815083B2 (ja) 1999-08-31 2011-11-16 メルク・シャープ・エンド・ドーム・コーポレイション 複素環化合物およびそれの使用方法
WO2002046166A1 (fr) 2000-12-04 2002-06-13 F. Hoffmann-La Roche Ag Derives phenylethenyle ou phenylethinyle servant d'antagonistes de recepteur de glutamate
WO2003053922A2 (fr) * 2001-12-19 2003-07-03 Merck & Co., Inc. Imidazoles substitues par heteroaryle modulateurs du recepteur metabotropique du glutamate de type 5

Also Published As

Publication number Publication date
IL170129A (en) 2013-02-28
PL1606277T3 (pl) 2008-10-31
MY135491A (en) 2008-04-30
CN1759111A (zh) 2006-04-12
BRPI0408093A (pt) 2006-02-14
KR100742019B1 (ko) 2007-07-23
HK1089443A1 (zh) 2006-12-01
NO20054136D0 (no) 2005-09-06
CL2004000449A1 (es) 2005-01-07
WO2004080998A1 (fr) 2004-09-23
KR20050109074A (ko) 2005-11-17
AU2004220382A1 (en) 2004-09-23
SI1606277T1 (sl) 2008-08-31
AR043501A1 (es) 2005-08-03
NO20054136L (no) 2005-09-26
EP1606277B1 (fr) 2008-05-14
ZA200506834B (en) 2006-05-31
CA2516682C (fr) 2010-02-02
JP2006519802A (ja) 2006-08-31
ES2305739T3 (es) 2008-11-01
CA2516682A1 (fr) 2004-09-23
RU2342383C2 (ru) 2008-12-27
PE20041061A1 (es) 2005-01-22
TW200423935A (en) 2004-11-16
MXPA05009524A (es) 2005-10-18
JP4404896B2 (ja) 2010-01-27
CN100358889C (zh) 2008-01-02
CO5601027A2 (es) 2006-01-31
US20040229917A1 (en) 2004-11-18
EP1606277B8 (fr) 2008-10-15
AU2004220382B2 (en) 2007-08-02
HRP20050774A2 (en) 2006-09-30
TWI292318B (en) 2008-01-11
PA8597301A1 (es) 2004-09-16
EP1606277A1 (fr) 2005-12-21
US7153874B2 (en) 2006-12-26
NZ541643A (en) 2008-03-28
DE602004013746D1 (de) 2008-06-26
RU2005131165A (ru) 2007-04-20
ATE395345T1 (de) 2008-05-15
PT1606277E (pt) 2008-07-08

Similar Documents

Publication Publication Date Title
ATE340782T1 (de) Piperidinbenzolsulfonamidderivate
ATE352550T1 (de) Chinazolinderivate
ATE420066T1 (de) Amidoacetonitrilderivate
ATE478870T1 (de) Spiroindolinpiperidinderivate
ATE460418T1 (de) Heterocyclocarboxamidderivate
DK1551802T3 (da) Indol-3-svovlderivater
ATE467631T1 (de) Chinuclidinamidderivate
ATE438644T1 (de) Chinazolinderivate
IS7720A (is) Píperidín-N-oxíð-afleiður
DK1474408T3 (da) N-Phenyl-2-pyrimidinaminderivater
ATE395345T1 (de) Imidazol-4-yl-ethynyl-pyridin-derivate
DE50311137D1 (de) Eriebauteile
IS2656B (is) Nýjar besímídasólafleiður
AT502792A5 (de) Düsenanpressvorrichtung
DE602004001602D1 (de) Motorluftansaugkrümmer
DE502004007911D1 (de) Wischblatt
DE60307512D1 (de) 3h-chinazoline -4-on derivaten
ATE354365T1 (de) N-thiazol-2-yl-benzamid-derivate
ATE423771T1 (de) Tetrahydrochinolinderivate
ATE449064T1 (de) Amidoacetonitrilderivate
DE602004002038D1 (de) Buschschneider
IS8045A (is) Púrín-6-ón-afleiður
DE50306277D1 (de) 4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate
DE502004010244D1 (de) En
DE502004008889D1 (de) Schaltgabel